RZLTRezolute, Inc.

Nasdaq rezolutebio.com


$ 3.38 $ 0.34 (11.45 %)    

Friday, 03-May-2024 15:54:44 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 3.31
$ 3.11
$ 0.00 x 0
$ 0.00 x 0
$ 3.06 - $ 3.38
$ 0.72 - $ 3.69
335,692
na
170.16M
$ 31.87
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-13-2024 12-31-2023 10-Q
2 11-13-2023 09-30-2023 10-Q
3 09-14-2023 06-30-2023 10-K
4 05-11-2023 03-31-2023 10-Q
5 02-10-2023 12-31-2022 10-Q
6 11-09-2022 09-30-2022 10-Q
7 09-15-2022 06-30-2022 10-K
8 05-12-2022 03-31-2022 10-Q
9 02-09-2022 12-31-2021 10-Q
10 11-12-2021 09-30-2021 10-Q
11 09-15-2021 06-30-2021 10-K
12 05-17-2021 03-31-2021 10-Q
13 02-10-2021 12-31-2020 10-Q
14 11-12-2020 09-30-2020 10-Q
15 10-13-2020 06-30-2020 10-K
16 05-14-2020 03-31-2020 10-Q
17 02-12-2020 12-31-2019 10-Q
18 11-14-2019 09-30-2019 10-Q
19 09-10-2019 06-30-2019 10-K
20 05-10-2019 03-31-2019 10-Q
21 02-14-2019 12-31-2018 10-Q
22 12-14-2018 09-30-2018 10-Q
23 10-15-2018 06-30-2018 10-K
24 05-15-2018 03-31-2018 10-Q
25 02-14-2018 12-31-2017 10-Q
26 11-14-2017 09-30-2017 10-Q
27 09-22-2017 06-30-2017 10-K
28 05-15-2017 03-31-2017 10-Q
29 02-02-2017 12-31-2016 10-Q
30 11-14-2016 09-30-2016 10-Q
31 09-28-2016 06-30-2016 10-K
32 05-16-2016 03-31-2016 10-Q
33 02-16-2016 12-31-2015 10-Q
34 11-16-2015 09-30-2015 10-Q
35 09-28-2015 06-30-2015 10-K
36 05-15-2015 03-31-2015 10-Q
37 02-17-2015 12-31-2014 10-Q
38 11-12-2014 09-30-2014 10-Q
39 09-30-2014 06-30-2014 10-K
40 05-14-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jmp-securities-reiterates-market-outperform-on-rezolute-maintains-7-price-target

JMP Securities analyst Jason Butler reiterates Rezolute (NASDAQ:RZLT) with a Market Outperform and maintains $7 price target.

 jmp-securities-reiterates-market-outperform-on-rezolute-maintains-7-price-target

JMP Securities analyst Jason Butler reiterates Rezolute (NASDAQ:RZLT) with a Market Outperform and maintains $7 price target.

 jonestrading-initiates-coverage-on-rezolute-with-buy-rating-announces-price-target-of-10

JonesTrading analyst Catherine Novack initiates coverage on Rezolute (NASDAQ:RZLT) with a Buy rating and announces Price Tar...

 maxim-group-initiates-coverage-on-rezolute-with-buy-rating-announces-price-target-of-8

Maxim Group analyst Jason McCarthy initiates coverage on Rezolute (NASDAQ:RZLT) with a Buy rating and announces Price Target...

 commscope-holding-and-2-other-stocks-under-3-insiders-are-buying

The Dow Jones index closed higher by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confide...

 17m-bet-on-this-healthcare-stock-check-out-these-4-penny-stocks-insiders-are-aggressively-buying

The Dow Jones index closed higher by over 300 points on Tuesday. When insiders purchase or sell shares, it indicates their conf...

 15m-bet-on-this-penny-stock-check-out-these-4-stocks-under-5-insiders-are-aggressively-buying

The Dow Jones index closed lower by around 0.2% on Friday. When insiders purchase or sell shares, it indicates their confidence...

 hc-wainwright--co-reiterates-buy-on-rezolute-maintains-14-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Rezolute (NASDAQ:RZLT) with a Buy and maintains $14 price target.

 lumen-technologies-and-3-other-stocks-under-3-insiders-are-buying

The Dow Jones index closed lower by around 100 points on Tuesday. When insiders purchase or sell shares, it indicates their con...

 charles--colvard-and-3-other-stocks-under-2-insiders-are-buying

The Dow Jones index closed higher by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confid...

 rezolute-and-3-other-penny-stocks-insiders-are-buying

The Dow Jones index closed lower by more than 60 points on Tuesday. When insiders purchase or sell shares, it indicates their c...

 hc-wainwright--co-reiterates-buy-on-rezolute-maintains-14-price-target

HC Wainwright & Co. analyst Douglas Tsao reiterates Rezolute (NASDAQ:RZLT) with a Buy and maintains $14 price target.

 rezolute-q2-eps-027-beats-030-estimate

Rezolute (NASDAQ:RZLT) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.30) by 1...

 rezolute-expands-leadership-team-with-appointment-of-daron-evans-ms-mba-as-chief-financial-officer

Rezolute, Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapie...

 rezolute-receives-innovation-passport-designation-from-the-uk-innovative-licensing-and-access-pathway-steering-group-for-rz358-in-the-treatment-of-hypoglycemia-due-to-congenital-hyperinsulinism

Rezolute, Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative therapie...

 why-aclarion-shares-are-trading-higher-by-around-53-here-are-20-stocks-moving-premarket

Shares of Aclarion, Inc. (NASDAQ: ACON) shares rose sharply in pre-market trading after the company was granted U.S. patent #1...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION